Koru Medical Systems raised its FY2026 revenue guidance to $48 million–$48.5 million, shifting the midpoint of its revenue outlook higher. The surprise is in the revenue figures; it does not involve token demand or on-chain data.

Binance $KORU U.S. stock perpetuals had already rallied ahead of the news, and the price is still holding near its highs, while 6-hour OI has fallen to -2.1%. With price near its previous high and open interest shrinking, this looks more like existing positions taking profit, without new money entering in step.

For now, the focus is solely on support after the repricing. If price keeps rising while OI continues to move further into negative territory, the rally’s follow-through will look increasingly hollow. Only if OI turns positive again after price stabilizes, with trading volume picking up, will that count as new money truly taking over.